Ubs Asset Management Americas Inc Axsome Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 47,714 shares of AXSM stock, worth $4.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,714

Previous 56,193 15.09%

Holding current value

$4.45 Million

Previous $4.52 Million 5.22%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $669,247 - $812,627	-8,479 Reduced 15.09%	47,714 $4.29 Million
Q2 2024 Aug 13, 2024	BUY	$65.72 - $80.5 $1.8 Million - $2.2 Million	27,352 Added 94.84%	56,193 $4.52 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $81,047 - $114,043	-1,168 Reduced 3.89%	28,841 $2.3 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $252,131 - $367,131	-4,391 Reduced 12.76%	30,009 $2.39 Million
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $662,376 - $786,338	9,565 Added 38.51%	34,400 $2.4 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $123,728 - $158,925	-2,119 Reduced 7.86%	24,835 $1.53 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $77,922 - $155,533	1,951 Added 7.8%	26,954 $2.08 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $105,872 - $205,079	2,936 Added 13.3%	25,003 $1.12 Million
Q2 2022 Aug 12, 2022	SELL	$21.74 - $46.75 $19,392 - $41,701	-892 Reduced 3.89%	22,067 $845,000
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $92,900 - $318,501	-4,666 Reduced 16.89%	22,959 $756,000
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $140,650 - $204,183	2,778 Added 11.18%	27,625 $1.86 Million
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $122,778 - $178,842	-2,196 Reduced 8.12%	24,847 $1.41 Million
Q4 2020 Mar 01, 2021	SELL	$66.31 - $86.52 $41,775 - $54,507	-630 Reduced 2.28%	27,043 $2.2 Million
Q3 2020 Nov 13, 2020	BUY	$68.34 - $85.84 $37,245 - $46,782	545 Added 2.01%	27,673 $1.97 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $430,627 - $852,188	8,635 Added 46.69%	27,128 $2.23 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $198,378 - $487,807	-4,815 Reduced 20.66%	18,493 $1.09 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $168,169 - $1.07 Million	10,064 Added 75.99%	23,308 $2.41 Million
Q3 2019 Nov 14, 2019	SELL	$20.24 - $29.16 $202,055 - $291,104	-9,983 Reduced 42.98%	13,244 $268,000
Q2 2019 Aug 15, 2019	BUY	$13.46 - $25.75 $312,635 - $598,095	23,227 New	23,227 $0

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Axsome Therapeutics, Inc. Transaction History